Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

PHASE2CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

June 25, 2020

Primary Completion Date

January 19, 2021

Study Completion Date

June 19, 2021

Conditions

SARS-Associated CoronavirusCovid19SARS-CoV Infection

Interventions

BIOLOGICAL

Convalescent plasma

Convalescent plasma from patients recovering from Covid-19 and which had anti-SARS-Cov-2 antibodies

Trial Locations (1)

Hospital Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aire

All Listed Sponsors

lead

Hospital de Infecciosas Francisco Javier Muniz

OTHER_GOV

NCT04468009 - Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma | Biotech Hunter | Biotech Hunter